Transcription of SYSTEMIC LUPUS ERYTH EMATOSUS: PATHOGENESIS, …
{{id}} {{{paragraph}}}
Eular On-line Course on Rheumatic Diseases module n 17 Ricard Cervera, Gerard Espinosa, David D Cruz 1 2007-2009 EULAR SYSTEMIC LUPUS ERYTHEMATOSUS: pathogenesis , CLINICAL MANIFESTATIONS AND DIAGNOSIS INTRODUCTION SYSTEMIC LUPUS erythematosus (SLE) is a multisystem autoimmune disorder with a broad spectrum of clinical presentations (1). There is a peak age of onset among young women between the late teens and early 40 s and a female to male ratio of 9:1. Ethnic groups such as those with African or Asian ancestry are more at risk of developing the disorder and it may be more severe compared to Caucasian patients.
Eular On-line Course on Rheumatic Diseases – module n°17 Ricard Cervera, Gerard Espinosa, David D’Cruz 1 ©2007-2009 EULAR SYSTEMIC LUPUS ERYTH EMATOSUS:
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Extravasation Classification of Systemic Anti, Systemic Anti, Systemic Insecticide, Anti, Systemic Anti-Cancer Therapy Safe Handling, Systemic Anti-Cancer Therapy Safe Handling and Drug Administration, Stages of Anti, Systemic lupus, Diagnosis and Treatment of Systemic, Diagnosis and treatment of, NOTICE OF FILING, FEDERAL COURT OF AUSTRALIA